Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses

Journal of Proteome Research

Volumn 12, Issue 12, 2013, Pages 5642-5655

  Brambilla, Francesca ^a   Lavatelli, Francesca ^b   Di Silvestre, Dario ^a   Valentini, Veronica ^b   Palladini, Giovanni ^b,c   Merlini, Giampaolo ^b,c   Mauri, Pierluigi ^a,d  

^a CNR   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

amyloid; amyloidosis; human adipose tissue; label free; MudPIT

Indexed keywords

ABDOMINAL FAT; ADIPOSE TISSUE; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FINE NEEDLE ASPIRATION BIOPSY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; CASE CONTROL STUDY; CHEMISTRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN ANALYSIS; TANDEM MASS SPECTROMETRY;

AMYLOID; MITOCHONDRIAL PROTEIN;

ADIPOSE TISSUE; AMYLOID; AMYLOIDOSIS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; LIPID METABOLISM; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE ANNOTATION; PROTEIN FOLDING; PROTEIN INTERACTION MAPPING; TANDEM MASS SPECTROMETRY;

EID: 84890096954     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400583h     Document Type: Article

References (90)

1. Merlini, G.; Bellotti, V. Molecular mechanisms of amyloidosis N. Engl. J. Med. 2003, 349 (6) 583-96
2. Pepys, M. B. Amyloidosis Annu. Rev. Med. 2006, 57, 223-41
3. Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S.; Merlini, G.; Saraiva, M. J.; Westermark, P.; Amyloidosis, N. C. o. t. I. S. o. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 2012, 19 (4) 167-70
4. Obici, L.; Perfetti, V.; Palladini, G.; Moratti, R.; Merlini, G. Clinical aspects of systemic amyloid diseases Biochim. Biophys. Acta 2005, 1753 (1) 11-22
5. Lavatelli, F.; Vrana, J. A. Proteomic typing of amyloid deposits in systemic amyloidoses Amyloid 2011, 18 (4) 177-82
6. Brambilla, F.; Lavatelli, F.; Valentini, V.; Di Silvestre, D.; Obici, L.; Mauri, P.; Merlini, G. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis Amyloid 2012, 19 (Suppl 1) 11-3
7. Vrana, J. A.; Gamez, J. D.; Madden, B. J.; Theis, J. D.; Bergen, H. R.; Dogan, A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens Blood 2009, 114 (24) 4957-9
8. Lavatelli, F.; Perlman, D. H.; Spencer, B.; Prokaeva, T.; McComb, M. E.; Théberge, R.; Connors, L. H.; Bellotti, V.; Seldin, D. C.; Merlini, G.; Skinner, M.; Costello, C. E. Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue Mol. Cell. Proteomics 2008, 7 (8) 1570-83
9. Brambilla, F.; Lavatelli, F.; Di Silvestre, D.; Valentini, V.; Rossi, R.; Palladini, G.; Obici, L.; Verga, L.; Mauri, P.; Merlini, G. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue Blood 2012, 119 (8) 1844-7
10. Westermark, P.; Davey, E.; Lindbom, K.; Enqvist, S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis Acta Histochem. 2006, 108 (3) 209-13
11. van Gameren, I. I.; Hazenberg, B. P.; Bijzet, J.; van Rijswijk, M. H. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice Arthritis Rheum. 2006, 54 (6) 2015-21
12. Caccialanza, R.; Palladini, G.; Klersy, C.; Cereda, E.; Bonardi, C.; Cameletti, B.; Montagna, E.; Russo, P.; Foli, A.; Milani, P.; Lavatelli, F.; Merlini, G. Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis Ann. Hematol. 2012, 91 (3) 399-406
13. Caccialanza, R.; Palladini, G.; Klersy, C.; Cena, H.; Vagia, C.; Cameletti, B.; Russo, P.; Lavatelli, F.; Merlini, G. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1 Am. J. Clin. Nutr. 2006, 83 (2) 350-4
14. Wolters, D. A.; Washburn, M. P.; Yates, J. R. An automated multidimensional protein identification technology for shotgun proteomics Anal. Chem. 2001, 73 (23) 5683-90
15. Washburn, M. P.; Wolters, D.; Yates, J. R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology Nat. Biotechnol. 2001, 19 (3) 242-7
16. De Palma, A.; Roveri, A.; Zaccarin, M.; Benazzi, L.; Daminelli, S.; Pantano, G.; Buttarello, M.; Ursini, F.; Gion, M.; Mauri, P. L. Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis J. Chromatogr. A 2010, 1217 (33) 5328-36
17. Bellotti, V.; Chiti, F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases Curr. Opin. Struct. Biol. 2008, 18 (6) 771-9
18. Elimova, E.; Kisilevsky, R.; Szarek, W. A.; Ancsin, J. B. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy FASEB J. 2004, 18 (14) 1749-51
19. Relini, A.; Canale, C.; De Stefano, S.; Rolandi, R.; Giorgetti, S.; Stoppini, M.; Rossi, A.; Fogolari, F.; Corazza, A.; Esposito, G.; Gliozzi, A.; Bellotti, V. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis J. Biol. Chem. 2006, 281 (24) 16521-9
20. Hazenberg, B. P.; Bijzet, J.; Limburg, P. C.; Skinner, M.; Hawkins, P. N.; Butrimiene, I.; Livneh, A.; Lesnyak, O.; Nasonov, E. L.; Filipowicz-Sosnowska, A.; Gül, A.; Merlini, G.; Wiland, P.; Ozdogan, H.; Gorevic, P. D.; Maïz, H. B.; Benson, M. D.; Direskeneli, H.; Kaarela, K.; Garceau, D.; Hauck, W.; Van Rijswijk, M. H. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis Amyloid 2007, 14 (2) 133-40
21. Arbustini, E.; Verga, L.; Concardi, M.; Palladini, G.; Obici, L.; Merlini, G. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis Amyloid 2002, 9 (2) 108-14
22. Comunian, C.; Rusconi, F.; De Palma, A.; Brunetti, P.; Catalucci, D.; Mauri, P. L. A comparative MudPIT analysis identifies different expression profiles in heart compartments Proteomics 2011, 11 (11) 2320-8
23. Mauri, P.; Scarpa, A.; Nascimbeni, A. C.; Benazzi, L.; Parmagnani, E.; Mafficini, A.; Della Peruta, M.; Bassi, C.; Miyazaki, K.; Sorio, C. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers FASEB J. 2005, 19 (9) 1125-7
24. Mauri, P.; Dehò, G. A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli Methods Enzymol. 2008, 447, 99-117
25. Avila-Campillo, I.; Drew, K.; Lin, J.; Reiss, D. J.; Bonneau, R. BioNetBuilder: automatic integration of biological networks Bioinformatics 2007, 23 (3) 392-3
26. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 2003, 13 (11) 2498-504
27. Cline, M. S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2007, 2 (10) 2366-82
28. Maere, S.; Heymans, K.; Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks Bioinformatics 2005, 21 (16) 3448-9
29. Bader, G. D.; Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks BMC Bioinformatics 2003, 4, 2
30. Zhong, J.; Krawczyk, S. A.; Chaerkady, R.; Huang, H.; Goel, R.; Bader, J. S.; Wong, G. W.; Corkey, B. E.; Pandey, A. Temporal profiling of the secretome during adipogenesis in humans J. Proteome Res. 2010, 9 (10) 5228-38
31. Bouwman, F. G.; Claessens, M.; van Baak, M. A.; Noben, J. P.; Wang, P.; Saris, W. H.; Mariman, E. C. The physiologic effects of caloric restriction are reflected in the in vivo adipocyte-enriched proteome of overweight/obese subjects J. Proteome Res. 2009, 8 (12) 5532-40
32. Chen, X.; Hess, S. Adipose proteome analysis: focus on mediators of insulin resistance Expert Rev. Proteomics 2008, 5 (6) 827-39
33. Lee, M. J.; Kim, J.; Kim, M. Y.; Bae, Y. S.; Ryu, S. H.; Lee, T. G.; Kim, J. H. Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells J. Proteome Res. 2010, 9 (4) 1754-62
34. Kim, B. S.; Kang, K. S.; Kang, S. K. Soluble factors from ASCs effectively direct control of chondrogenic fate Cell Prolif. 2010, 43 (3) 249-61
35. Mukherjee, R.; Choi, J. W.; Choi, D. K.; Oh, T. S.; Liu, H.; Yun, J. W. Gender-dependent protein expression in white adipose tissues of lean and obese rats fed a high fat diet Cell Physiol. Biochem. 2012, 29 (3-4) 617-34
36. Pérez-Pérez, R.; López, J. A.; García-Santos, E.; Camafeita, E.; Gómez-Serrano, M.; Ortega-Delgado, F. J.; Ricart, W.; Fernández-Real, J. M.; Peral, B. Uncovering suitable reference proteins for expression studies in human adipose tissue with relevance to obesity PLoS One 2012, 7 (1) e30326
37. Boden, G.; Merali, S. Measurement of the increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals Methods Enzymol. 2011, 489, 67-82
38. Leggate, M.; Carter, W. G.; Evans, M. J.; Vennard, R. A.; Sribala-Sundaram, S.; Nimmo, M. A. Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males J. Appl. Physiol. 2012, 112 (8) 1353-60
39. Grau, S.; Baldi, A.; Bussani, R.; Tian, X.; Stefanescu, R.; Przybylski, M.; Richards, P.; Jones, S. A.; Shridhar, V.; Clausen, T.; Ehrmann, M. Implications of the serine protease HtrA1 in amyloid precursor protein processing Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (17) 6021-6
40. Yerbury, J. J.; Poon, S.; Meehan, S.; Thompson, B.; Kumita, J. R.; Dobson, C. M.; Wilson, M. R. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J. 2007, 21 (10) 2312-22
41. Shammas, S. L.; Waudby, C. A.; Wang, S.; Buell, A. K.; Knowles, T. P.; Ecroyd, H.; Welland, M. E.; Carver, J. A.; Dobson, C. M.; Meehan, S. Binding of the molecular chaperone αB-Crystallin to Aβ amyloid fibrils inhibits fibril elongation Biophys. J. 2011, 101 (7) 1681-9
42. Narayan, P.; Meehan, S.; Carver, J. A.; Wilson, M. R.; Dobson, C. M.; Klenerman, D. Amyloid-β oligomers are sequestered by both intracellular and extracellular chaperones Biochemistry 2012, 51 (46) 9270-6
43. Kumita, J. R.; Poon, S.; Caddy, G. L.; Hagan, C. L.; Dumoulin, M.; Yerbury, J. J.; Stewart, E. M.; Robinson, C. V.; Wilson, M. R.; Dobson, C. M. The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species J. Mol. Biol. 2007, 369 (1) 157-67
44. Magalhães, J.; Saraiva, M. J. The heat shock response in FAP: the role of the extracellular chaperone clusterin Amyloid 2012, 19 (Suppl 1) 3-4
45. Magalhães, J.; Saraiva, M. J. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy J. Neuropathol. Exp. Neurol. 2011, 70 (12) 1097-106
46. Magalhães, J.; Santos, S. D.; Saraiva, M. J. αB-Crystallin (HspB5) in familial amyloidotic polyneuropathy Int. J. Exp. Pathol. 2010, 91 (6) 515-21
47. Esposito, G.; Garvey, M.; Alverdi, V.; Pettirossi, F.; Corazza, A.; Fogolari, F.; Polano, M.; Mangione, P. P.; Giorgetti, S.; Stoppini, M.; Rekas, A.; Bellotti, V.; Heck, A. J.; Carver, J. A. Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-Crystallin by NMR and mass spectrometry. αB-Crystallin dissociates β2-microglobulin oligomers J. Biol. Chem. 2013, 10.1074/jbc.M112.448639
48. Zabel, C.; Sagi, D.; Kaindl, A. M.; Steireif, N.; Kläre, Y.; Mao, L.; Peters, H.; Wacker, M. A.; Kleene, R.; Klose, J. Comparative proteomics in neurodegenerative and non-neurodegenerative diseases suggest nodal point proteins in regulatory networking J. Proteome Res. 2006, 5 (8) 1948-58
49. Wilhelmus, M. M.; Otte-Höller, I.; Wesseling, P.; de Waal, R. M.; Boelens, W. C.; Verbeek, M. M. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains Neuropathol. Appl. Neurobiol. 2006, 32 (2) 119-30
50. Bianchi, F. T.; Camera, P.; Ala, U.; Imperiale, D.; Migheli, A.; Boda, E.; Tempia, F.; Berto, G.; Bosio, Y.; Oddo, S.; LaFerla, F. M.; Taraglio, S.; Dotti, C. G.; Di Cunto, F. The collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptides PLoS One 2011, 6 (7) e22370
51. Hoshino, T.; Murao, N.; Namba, T.; Takehara, M.; Adachi, H.; Katsuno, M.; Sobue, G.; Matsushima, T.; Suzuki, T.; Mizushima, T. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice J. Neurosci. 2011, 31 (14) 5225-34
52. Chien, V.; Aitken, J. F.; Zhang, S.; Buchanan, C. M.; Hickey, A.; Brittain, T.; Cooper, G. J.; Loomes, K. M. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes Biochem. J. 2010, 432 (1) 113-21
53. Santos, S. D.; Fernandes, R.; Saraiva, M. J. The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems Neurobiol. Aging 2010, 31 (2) 280-9
54. Yerbury, J. J.; Stewart, E. M.; Wyatt, A. R.; Wilson, M. R. Quality control of protein folding in extracellular space EMBO Rep. 2005, 6 (12) 1131-6
55. Hatters, D. M.; Wilson, M. R.; Easterbrook-Smith, S. B.; Howlett, G. J. Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin Eur. J. Biochem. 2002, 269 (11) 2789-94
56. Oda, T.; Wals, P.; Osterburg, H. H.; Johnson, S. A.; Pasinetti, G. M.; Morgan, T. E.; Rozovsky, I.; Stine, W. B.; Snyder, S. W.; Holzman, T. F. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress Exp. Neurol. 1995, 136 (1) 22-31
57. Greene, M. J.; Sam, F.; Soo Hoo, P. T.; Patel, R. S.; Seldin, D. C.; Connors, L. H. Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy Am. J. Pathol. 2011, 178 (1) 61-8
58. Lee, K. W.; Lee, D. H.; Son, H.; Kim, Y. S.; Park, J. Y.; Roh, G. S.; Kim, H. J.; Kang, S. S.; Cho, G. J.; Choi, W. S. Clusterin regulates transthyretin amyloidosis Biochem. Biophys. Res. Commun. 2009, 388 (2) 256-60
59. Pepys, M. B.; Rademacher, T. W.; Amatayakul-Chantler, S.; Williams, P.; Noble, G. E.; Hutchinson, W. L.; Hawkins, P. N.; Nelson, S. R.; Gallimore, J. R.; Herbert, J. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (12) 5602-6
60. Gallo, G.; Wisniewski, T.; Choi-Miura, N. H.; Ghiso, J.; Frangione, B. Potential role of apolipoprotein-E in fibrillogenesis Am. J. Pathol. 1994, 145 (3) 526-30
61. Bergström, J.; Murphy, C.; Eulitz, M.; Weiss, D. T.; Westermark, G. T.; Solomon, A.; Westermark, P. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis Biochem. Biophys. Res. Commun. 2001, 285 (4) 903-8
62. Relini, A.; De Stefano, S.; Torrassa, S.; Cavalleri, O.; Rolandi, R.; Gliozzi, A.; Giorgetti, S.; Raimondi, S.; Marchese, L.; Verga, L.; Rossi, A.; Stoppini, M.; Bellotti, V. Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen J. Biol. Chem. 2008, 283 (8) 4912-20
63. Monis, G. F.; Schultz, C.; Ren, R.; Eberhard, J.; Costello, C.; Connors, L.; Skinner, M.; Trinkaus-Randall, V. Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts Am. J. Pathol. 2006, 169 (6) 1939-52
64. Misumi, Y.; Ueda, M.; Obayashi, K.; Jono, H.; Yamashita, T.; Ando, Y. Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy Amyloid 2012, 19 (Suppl 1) 8-10
65. Khan, T.; Muise, E. S.; Iyengar, P.; Wang, Z. V.; Chandalia, M.; Abate, N.; Zhang, B. B.; Bonaldo, P.; Chua, S.; Scherer, P. E. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI Mol. Cell. Biol. 2009, 29 (6) 1575-91
66. Cheng, J. S.; Dubal, D. B.; Kim, D. H.; Legleiter, J.; Cheng, I. H.; Yu, G. Q.; Tesseur, I.; Wyss-Coray, T.; Bonaldo, P.; Mucke, L. Collagen VI protects neurons against Abeta toxicity Nat. Neurosci. 2009, 12 (2) 119-21
67. Cohlberg, J. A.; Li, J.; Uversky, V. N.; Fink, A. L. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro Biochemistry 2002, 41 (5) 1502-11
68. Ren, R.; Hong, Z.; Gong, H.; Laporte, K.; Skinner, M.; Seldin, D. C.; Costello, C. E.; Connors, L. H.; Trinkaus-Randall, V. Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils J. Biol. Chem. 2010, 285 (48) 37672-82
69. Trinkaus-Randall, V.; Walsh, M. T.; Steeves, S.; Monis, G.; Connors, L. H.; Skinner, M. Cellular response of cardiac fibroblasts to amyloidogenic light chains Am. J. Pathol. 2005, 166 (1) 197-208
70. Lindahl, B.; Eriksson, L.; Spillmann, D.; Caterson, B.; Lindahl, U. Selective loss of cerebral keratan sulfate in Alzheimer's disease J. Biol. Chem. 1996, 271 (29) 16991-4
71. Noborn, F.; O'Callaghan, P.; Hermansson, E.; Zhang, X.; Ancsin, J. B.; Damas, A. M.; Dacklin, I.; Presto, J.; Johansson, J.; Saraiva, M. J.; Lundgren, E.; Kisilevsky, R.; Westermark, P.; Li, J. P. Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (14) 5584-9
72. Kisilevsky, R.; Ancsin, J. B.; Szarek, W. A.; Petanceska, S. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications Amyloid 2007, 14 (1) 21-32
73. Westermark, G. T.; Norling, B.; Westermark, P. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis Clin. Exp. Immunol. 1991, 86 (1) 150-6
74. Eprodisate for AA Amyloidosis Trial Group; Dember, L. M.; Hawkins, P. N.; Hazenberg, B. P.; Gorevic, P. D.; Merlini, G.; Butrimiene, I.; Livneh, A.; Lesnyak, O.; Puéchal, X.; Lachmann, H. J.; Obici, L.; Balshaw, R.; Garceau, D.; Hauck, W.; Skinner, M. Eprodisate for the treatment of renal disease in AA amyloidosis N. Engl. J. Med. 2007, 356 (23) 2349-60
75. Li, J. P.; Galvis, M. L.; Gong, F.; Zhang, X.; Zcharia, E.; Metzger, S.; Vlodavsky, I.; Kisilevsky, R.; Lindahl, U. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (18) 6473-7
76. Motamedi-Shad, N.; Garfagnini, T.; Penco, A.; Relini, A.; Fogolari, F.; Corazza, A.; Esposito, G.; Bemporad, F.; Chiti, F. Rapid oligomer formation of human muscle acylphosphatase induced by heparan sulfate Nat. Struct. Mol. Biol. 2012, 19 (5) 547-54 S1-2
77. Castillo, G. M.; Lukito, W.; Peskind, E.; Raskind, M.; Kirschner, D. A.; Yee, A. G.; Snow, A. D. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain J. Neurosci. Res. 2000, 62 (3) 451-62
78. Woodrow, S. I.; Stewart, R. J.; Kisilevsky, R.; Gore, J.; Young, I. D. Experimental AA amyloidogenesis is associated with differential expression of extracellular matrix genes Amyloid 1999, 6 (1) 22-30
79. Suh, J. H.; Jarad, G.; VanDeVoorde, R. G.; Miner, J. H. Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (37) 15348-53
80. Noakes, P. G.; Miner, J. H.; Gautam, M.; Cunningham, J. M.; Sanes, J. R.; Merlie, J. P. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1 Nat. Genet. 1995, 10 (4) 400-6
81. Tremblay, F.; Revett, T.; Huard, C.; Zhang, Y.; Tobin, J. F.; Martinez, R. V.; Gimeno, R. E. Bidirectional modulation of adipogenesis by the secreted protein Ccdc80/DRO1/URB J. Biol. Chem. 2009, 284 (12) 8136-47
82. Pawłowski, K.; Muszewska, A.; Lenart, A.; Szczepińska, T.; Godzik, A.; Grynberg, M. A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins BMC Genomics 2010, 11, 590
83. Tansey, J. T.; Sztalryd, C.; Hlavin, E. M.; Kimmel, A. R.; Londos, C. The central role of perilipin a in lipid metabolism and adipocyte lipolysis IUBMB Life 2004, 56 (7) 379-85
84. Fujiyoshi, M.; Tachikawa, M.; Ohtsuki, S.; Ito, S.; Uchida, Y.; Akanuma, S.; Kamiie, J.; Hashimoto, T.; Hosoya, K.; Iwatsubo, T.; Terasaki, T. Amyloid-β peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier J. Neurochem. 2011, 118 (3) 407-15
85. Donahue, J. E.; Flaherty, S. L.; Johanson, C. E.; Duncan, J. A.; Silverberg, G. D.; Miller, M. C.; Tavares, R.; Yang, W.; Wu, Q.; Sabo, E.; Hovanesian, V.; Stopa, E. G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease Acta Neuropathol. 2006, 112 (4) 405-15
86. Fuentealba, R. A.; Liu, Q.; Zhang, J.; Kanekiyo, T.; Hu, X.; Lee, J. M.; LaDu, M. J.; Bu, G. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking PLoS One 2010, 5 (7) e11884
87. Silva, D. F.; Selfridge, J. E.; Lu, J.; E, L.; Cardoso, S. M.; Swerdlow, R. H. Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention Adv. Pharmacol. 2012, 64, 83-126
88. Boyault, C.; Zhang, Y.; Fritah, S.; Caron, C.; Gilquin, B.; Kwon, S. H.; Garrido, C.; Yao, T. P.; Vourc'h, C.; Matthias, P.; Khochbin, S. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates Genes Dev. 2007, 21 (17) 2172-81
89. Kobayashi, T.; Manno, A.; Kakizuka, A. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates Genes Cells 2007, 12 (7) 889-901
90. Weihl, C. C. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis Curr. Alzheimer Res. 2011, 8 (3) 252-60